# Clonidine to Prevent Delirium After Electroconvulsive Therapy.

> **NCT04828226** · PHASE4 · RECRUITING · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 130 (estimated)

## Conditions studied

- Major Depressive Disorder
- Catatonia
- Bipolar Disorder
- Delirium Postseizure

## Interventions

- **DRUG:** Clonidine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04828226
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-04-27
- **Primary completion:** 2026-07-27
- **Final completion:** 2026-07-31
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2025-08-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04828226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04828226, "Clonidine to Prevent Delirium After Electroconvulsive Therapy.". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04828226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*